Last week, 32 out of 33 Hyperliquid stock and company-valuation-linked markets with over $10 million in open interest declined, with a median drop of 7.26%. This decline was more than double the 2.92% drop of the S&P 500-mapped contract on the same venue. Technology-related markets, including those tied to semiconductors, AI infrastructure, and high-valuation stocks, faced significant pressure, with some losing over 20%. Only four markets outperformed the benchmark, but they still ended the week lower overall.
Hyperliquid’s stock and company-valuation-linked markets saw a median drop of 7.26% last week, more than double the 2.92% decline of the S&P 500-mapped contract. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 04, 2026 22:22 WIB: out of 50 major cryptocurrencies, 45 rose and 4 fell today. Notable movers include ETH at Rp44.295.582 with a 6.49% increase, ALGO at Rp1.808 up 6.23%, and AAVE at Rp2.467.643 gaining 5.82%.
The global AI accelerator market is projected to grow from $151 billion in 2025 to $443 billion by 2030, with a compound annual growth rate of about 24%. This expansion is fueled by the rise of generative AI, large language models, and increased inve...
No7 Software has enhanced its Anchor Loyalty & Rewards app by integrating Shopify POS, allowing merchants to run a unified loyalty program across online stores and physical shops. Customers now maintain a single points balance, tier status, and refer...
A growing town replaced its inefficient IT request process of spreadsheets and emails with a centralized Microsoft Power Apps hub developed by eSoftware Associates. This hub integrates project intake, risk assessment, and PMO scoring into one platfor...
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
